GD2-Specific CAR T Cells Demonstrate Potent and Targeted Anti-Tumor Efficacy Against Melanoma In Vitro and In Vivo
GD2.CAR T cells demonstrate potent anti-tumor activity against melanoma <i>in vitro</i> and <i>in vivo</i>, highlighting their therapeutic potential and warranting further clinical investigation.
Authors
- Roman Perik-Zavodskii (ORCID: https://orcid.org/0000-0002-5055-4859)
- E. L. Zavjalov (ORCID: https://orcid.org/0000-0002-9412-3874)
- Saleh Alrhmoun (ORCID: https://orcid.org/0000-0003-0788-5385)
- Alaa Alsalloum (ORCID: https://orcid.org/0000-0002-4395-5822)
- Julia Shevchenko (ORCID: https://orcid.org/0000-0001-8773-0599)
- Olga I. Solovieva (ORCID: https://orcid.org/0000-0002-8218-2690)
- V.V. Kurilin (ORCID: https://orcid.org/0000-0002-5617-0450)
- Hiroshi Shiku (ORCID: https://orcid.org/0000-0002-0362-755X)
- С. В. Сенников (ORCID: https://orcid.org/0000-0002-7366-7768)
- Marina Volynets (ORCID: https://orcid.org/0000-0003-1683-8951)
- Julia Lopatnikova (ORCID: https://orcid.org/0000-0003-0089-5054)
- Julia Philippova (ORCID: https://orcid.org/0000-0002-1158-887X)
- Olga Perik-Zavosdkaia
- Marina Fisher
Institutions
- Mie University (JP)
- Research Institute of Fundamental and Clinical Immunology (RU)
- Institute of Cytology and Genetics (RU)
- Siberian Branch of the Russian Academy of Sciences (RU)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2025-08-25
- DOI
- https://doi.org/10.31083/fbl41221
- Citations
- 3
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 3.14